Alan A. Musso
Chief Financial Officer · Fulcrum Therapeutics, Inc.
Individual
- 2024
- Feb 4, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Alan A. Musso files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Tang - $1.49M in FULC purchases and sales in the last 12 months
- Voss Capital, LP - $551K in RNTX purchases and sales in the last 12 months
- Robert J. Gould - $507K in FULC purchases and sales in the last 12 months
- Alan Ezekowitz - $66K in FULC purchases and sales in the last 12 months
- Rickenbach Josef H. von - $50K in RNTX purchases and sales in the last 12 months
- Curtis Gale Oltmans - $45K in FULC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alan A. Musso?
Alan A. Musso is a corporate insider, tracked as Chief Financial Officer of Fulcrum Therapeutics, Inc. (FULC). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Alan A. Musso last file a Form 4?
The most recent primary Form 4 on record is dated 4 February 2026, one of 3 filings going back to 2024.
